255. CSIM- Top Papers of the Year 2024 Live Episode
The Intern At Work: Internal Medicine
00:00
Advancements in NASH Treatment
This chapter discusses the clinical trial of resmetron, a new medication for managing non-alcoholic steatohepatitis (NASH) and liver fibrosis. It explores the drug's mechanism as a thyroid hormone beta receptor agonist and presents promising results that suggest a breakthrough in treating these conditions.
Transcript
Play full episode
